In summary, we report for the first time that administration of FGF21 can significantly prevent lipotoxicity- and diabetes-induced early-stage renal apoptosis, hypertrophy, and dysfunction, and significant prevented renal lipid accumulation and subsequent inflammation, oxidative damage and fibrotic effect. The gene discussed is FGF21; the disease is diabetes mellitus.